Acutus Medical Return on Equity

Acutus Medical (AFIB) currently reports a ROE of 82.36%. That is above the Healthcare sector average of 21.28%. Use the charts on this page to explore Acutus Medical's ROE history and peer comparisons.

Acutus Medical's ROE of 82.36% is higher than the Healthcare sector average of 21.28%. That is roughly 287.0% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Acutus Medical's current 82.36% should be judged against Healthcare norms (sector average: 21.28%) and against AFIB's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 82.36%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.28%. From there, open related valuation or income-statement pages for Acutus Medical, and consider following AFIB for alerts when major investors trade the stock.

Acutus Medical is classified in the Healthcare sector. On ROE, it currently shows 82.36% versus a sector average near 21.28%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AFIB with unrelated industries.